Germany Nuclear Medicine Market Size & Outlook, 2023-2030
Germany nuclear medicine market, 2018-2030 (US$M)
Related Markets
Germany nuclear medicine market highlights
- The Germany nuclear medicine market generated a revenue of USD 642.0 million in 2023 and is expected to reach USD 1,318.0 million by 2030.
- The Germany market is expected to grow at a CAGR of 10.8% from 2024 to 2030.
- In terms of segment, diagnostics was the largest revenue generating product in 2023.
- Therapeutics is the most lucrative product segment registering the fastest growth during the forecast period.
Nuclear medicine market data book summary
| Market revenue in 2023 | USD 642.0 million |
| Market revenue in 2030 | USD 1,318.0 million |
| Growth rate | 10.8% (CAGR from 2023 to 2030) |
| Largest segment | Diagnostics |
| Fastest growing segment | Therapeutics |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics, Therapeutics |
| Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Jubilant Pharmova, Nordion, Bracco, Iren SpA, Abliva AB, Lantheus Holdings Inc, Eckert & Ziegler Bebig SA, Mallinckrodt PLC Ordinary Shares - New, Cardinal Health Inc |
Other key industry trends
- In terms of revenue, Germany accounted for 6.3% of the global nuclear medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany nuclear medicine market is projected to lead the regional market in terms of revenue in 2030.
- Netherlands is the fastest growing regional market in Europe and is projected to reach USD 279.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nuclear Medicine Market Scope
Nuclear Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Germany nuclear medicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nuclear medicine market will help companies and investors design strategic landscapes.
Diagnostics was the largest segment with a revenue share of 75.45% in 2023. Horizon Databook has segmented the Germany nuclear medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
Germany accounts for the largest share in Europe’s radiopharmaceuticals market. The country operates seven research reactors for the R&D of medical isotopes. Increasing investments in the development of nuclear medicine and rising healthcare expenditure are expected to contribute to the growth of the nuclear medicine market during the forecast period.
The federal government and other investors in Germany provide financial support for R&D activities related to 99Mo production. According to the International Atomic Energy Agency, in April 2019, Germany was committed toward strengthening its safety and enhancing its nuclear reactors.
For instance, in June 2020, ITM (ITM Isotope Technologies München AG) entered into two supply agreement with POINT Biopharma, Inc. for Endolucin Beta/no carrier-added (n.c.a) Lutetium-177 (177Lu) chloride, to help with clinical & commercial supply of PNT2002 (a 177Lu-PSMA radiopharmaceutical) to treat prostate cancer.
Reasons to subscribe to Germany nuclear medicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Germany nuclear medicine market databook
-
Our clientele includes a mix of nuclear medicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany nuclear medicine market , including forecasts for subscribers. This country databook contains high-level insights into Germany nuclear medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Germany nuclear medicine market size, by product, 2018-2030 (US$M)
Germany Nuclear Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
